Lance Roberts is a seasoned financial strategist and economist with more than 30 years of experience in investment management, private banking and venture capital. He currently serves as chief ...

Palantir stock continues to crush the broader market, but can the company sustain these gains over the next several months?

AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school ...

Palantir (NASDAQ:PLTR) is a colossal winner that’s just found a way to keep winning in 2025. With shares up more than 37% in ...

So, where will Palantir Technologies be in three years? Here is what investors might expect. Over time, AI is likely to ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

PLTR Keeps Breaking Records Palantir Technologies (NASDAQ:PLTR) closed at $154.86 per share yesterday, but is surging more ...

U.S. stocks have surged this summer to levels not seen in years thanks to very low borrowing costs. Yet record valuations, a ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

The yield on the 10-year hit a 52-week high of 4.896% on January 13, a week before Trump's second inauguration, and traded as ...

Shares of technology companies rose after Alphabet's earnings stoked speculation on artificial-intelligence peers. Shares of the Google owner rose as its investment in AI capabilities appeared to pay ...

In his most recent research note, Ives named Palantir as one of his top selections, stating that the business is in a good position to benefit from a surge in enterprise AI expenditure as companies ...